AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2019
Oct 30, 2019
33956_dirs_2019-10-29_8dfe7896-a948-4d27-8dae-6d1a1b941830.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-10-22
Reporting Person: SOSIN CLIFFORD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-22 | Common Stock | P | 80526 | $37.30 | Acquired | 2821310 | Indirect |
| 2019-10-23 | Common Stock | P | 316 | $37.57 | Acquired | 2821626 | Indirect |
| 2019-10-23 | Common Stock | P | 84 | $37.79 | Acquired | 2821710 | Indirect |
Footnotes
F1: 2,223,781 of these shares are owned directly by Sosin Partners, L.P., and Reporting Person is the Managing Member of CAS Investment Partners, LLC, which is investment manager to Sosin Partners, L.P. The remaining 597,929 shares are owned directly by CSWR Partners, L.P., and Reporting Person is the Managing Member of CAS Investment Partners, LLC, which is investment manager to CSWR Partners, L.P.
More from Cardlytics, Inc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19
Regulatory Filings
2026
Jan 26